Publishing research using ab120343? Please let us know so that we can cite the reference in this datasheet.

ab120343 has been referenced in 3 publications.

  • Bancila M  et al. Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats. Fundam Clin Pharmacol 25:469-78 (2011). PubMed: 21039820
  • Major TC  et al. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay. J Pharmacol Exp Ther 325:723-31 (2008). PubMed: 18326812
  • Clozel JP  et al. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl 15:S17-25 (1997). PubMed: 9481612

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"